Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 22111602)

1.

Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.

Brown KC, Hosseinipour MC, Hoskins JM, Thirumaran RK, Tien HC, Weigel R, Tauzie J, Shumba I, Lamba JK, Schuetz EG, McLeod HL, Kashuba AD, Corbett AH.

Pharmacogenomics. 2012 Jan;13(1):113-21. doi: 10.2217/pgs.11.132. Epub 2011 Nov 23.

2.

Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.

Mo SL, Liu YH, Duan W, Wei MQ, Kanwar JR, Zhou SF.

Curr Drug Metab. 2009 Sep;10(7):730-53. Review.

PMID:
19702527
3.

Genetic contribution to variable human CYP3A-mediated metabolism.

Lamba JK, Lin YS, Schuetz EG, Thummel KE.

Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. Review.

PMID:
12406645
4.

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

Staatz CE, Goodman LK, Tett SE.

Clin Pharmacokinet. 2010 Mar;49(3):141-75. doi: 10.2165/11317350-000000000-00000. Review.

PMID:
20170205
5.

CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Wang H, Tompkins LM.

Curr Drug Metab. 2008 Sep;9(7):598-610. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk